A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial.

WHO supports the harnessing of mobile technologies to improve access to smoking cessation services. As such, this study evaluated the effectiveness of smoking cessation services provided by community pharmacists using PharmQuit compared with standard care. The study was a prospective, multicenter, r...

Full description

Bibliographic Details
Main Authors: Narong Asayut, Phayom Sookaneknun Olson, Juntip Kanjanasilp, Preut Thanarat, Bhattaraporn Senkraigul, Chuthathip Sittisarn, Suratsawatee Suksawat
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0265483
_version_ 1828286958308163584
author Narong Asayut
Phayom Sookaneknun Olson
Juntip Kanjanasilp
Preut Thanarat
Bhattaraporn Senkraigul
Chuthathip Sittisarn
Suratsawatee Suksawat
author_facet Narong Asayut
Phayom Sookaneknun Olson
Juntip Kanjanasilp
Preut Thanarat
Bhattaraporn Senkraigul
Chuthathip Sittisarn
Suratsawatee Suksawat
author_sort Narong Asayut
collection DOAJ
description WHO supports the harnessing of mobile technologies to improve access to smoking cessation services. As such, this study evaluated the effectiveness of smoking cessation services provided by community pharmacists using PharmQuit compared with standard care. The study was a prospective, multicenter, randomized controlled trial that included 156 participants who were 18 years or older and smoked at least one cigarette daily for a month, were ready to quit, willing to participate, and had a smartphone. The study was performed at seven community pharmacies in three provinces in Thailand. Participants were allocated to the intervention (n = 78) and control groups (n = 78). Both groups received the usual smoking cessation services with pharmacotherapy and counseling from community pharmacists for 6 months. The intervention group received PharmQuit as an additional service. Both groups were scheduled for follow-up visits on days 7, 14, 30, 60, 120, and 180. The primary outcome was continuous abstinence rate on day 180. The secondary outcomes included 7-day point abstinence rate, number of cigarettes smoked per day, exhaled carbon monoxide levels, adherence rate to the program, and satisfaction with PharmQuit. An analysis using the intent-to-treat principle was performed. Smoking cessation rates and the number of cigarettes smoked per day were significantly higher during the follow-up visits in both groups (p < 0.05). However, there were no statistically significant differences between the two groups. The adherence rate to the smoking cessation program was higher in the intervention group than in the control group (74 days vs. 60 days, p > 0.05). The results showed the benefits of the contribution of community pharmacists. Although the inclusion of PharmQuit did not yield better results than pharmacists' counselling alone, it may help obtain better adherence to smoking cessation programs. Trial registration: Thai Clinical Trials Registry: TCTR20200925004 on September 25, 2020 -retrospectively registered, http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6841.
first_indexed 2024-04-13T09:40:42Z
format Article
id doaj.art-1cff8ddd9dd942e9afbd78ccb39a998b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T09:40:42Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-1cff8ddd9dd942e9afbd78ccb39a998b2022-12-22T02:51:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01173e026548310.1371/journal.pone.0265483A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial.Narong AsayutPhayom Sookaneknun OlsonJuntip KanjanasilpPreut ThanaratBhattaraporn SenkraigulChuthathip SittisarnSuratsawatee SuksawatWHO supports the harnessing of mobile technologies to improve access to smoking cessation services. As such, this study evaluated the effectiveness of smoking cessation services provided by community pharmacists using PharmQuit compared with standard care. The study was a prospective, multicenter, randomized controlled trial that included 156 participants who were 18 years or older and smoked at least one cigarette daily for a month, were ready to quit, willing to participate, and had a smartphone. The study was performed at seven community pharmacies in three provinces in Thailand. Participants were allocated to the intervention (n = 78) and control groups (n = 78). Both groups received the usual smoking cessation services with pharmacotherapy and counseling from community pharmacists for 6 months. The intervention group received PharmQuit as an additional service. Both groups were scheduled for follow-up visits on days 7, 14, 30, 60, 120, and 180. The primary outcome was continuous abstinence rate on day 180. The secondary outcomes included 7-day point abstinence rate, number of cigarettes smoked per day, exhaled carbon monoxide levels, adherence rate to the program, and satisfaction with PharmQuit. An analysis using the intent-to-treat principle was performed. Smoking cessation rates and the number of cigarettes smoked per day were significantly higher during the follow-up visits in both groups (p < 0.05). However, there were no statistically significant differences between the two groups. The adherence rate to the smoking cessation program was higher in the intervention group than in the control group (74 days vs. 60 days, p > 0.05). The results showed the benefits of the contribution of community pharmacists. Although the inclusion of PharmQuit did not yield better results than pharmacists' counselling alone, it may help obtain better adherence to smoking cessation programs. Trial registration: Thai Clinical Trials Registry: TCTR20200925004 on September 25, 2020 -retrospectively registered, http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6841.https://doi.org/10.1371/journal.pone.0265483
spellingShingle Narong Asayut
Phayom Sookaneknun Olson
Juntip Kanjanasilp
Preut Thanarat
Bhattaraporn Senkraigul
Chuthathip Sittisarn
Suratsawatee Suksawat
A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial.
PLoS ONE
title A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial.
title_full A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial.
title_fullStr A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial.
title_full_unstemmed A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial.
title_short A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial.
title_sort community pharmacist led smoking cessation intervention using a smartphone app pharmquit a randomized controlled trial
url https://doi.org/10.1371/journal.pone.0265483
work_keys_str_mv AT narongasayut acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT phayomsookaneknunolson acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT juntipkanjanasilp acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT preutthanarat acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT bhattarapornsenkraigul acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT chuthathipsittisarn acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT suratsawateesuksawat acommunitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT narongasayut communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT phayomsookaneknunolson communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT juntipkanjanasilp communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT preutthanarat communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT bhattarapornsenkraigul communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT chuthathipsittisarn communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial
AT suratsawateesuksawat communitypharmacistledsmokingcessationinterventionusingasmartphoneapppharmquitarandomizedcontrolledtrial